Levodopa in Parkinson??s Disease

This publication has 96 references indexed in Scilit:

• Chronic Treatment with Levodopa and/or Selegiline Does Not Affect Behavioral Recovery Induced by Fetal Ventral Mesencephalic Grafts in Unilaterally 6-Hydroxydopamine-Lesioned Rats
  Experimental Neurology, 1994
• A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
  Journal of Neurology, Neurosurgery & Psychiatry, 1994
• Ascorbic acid protects against levodopa‐induced neurotoxicity on a catecholamine‐rich human neuroblastoma cell line
  Movement Disorders, 1993
• Plasma Levels of Levodopa and Its Main Metabolites in Parkinsonian Patients after Conventional and Controlled-Release Levodopa-Carbidopa Associations
  European Neurology, 1993
• Dopamine increases the expression of tyrosine hydroxylase and aromatic amino acid decarboxylase in primary cultures of fetal neurons
  Developmental Brain Research, 1991
• Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture
  Journal of Neuroscience Research, 1990
• Mitochondrial Complex I Deficiency in Parkinson's Disease
  Journal of Neurochemistry, 1990
• Parkinson's Disease: Follow‐up After “Drug Holiday”
  The Journal of Clinical Pharmacology, 1986
• Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients
  Neuroscience Letters, 1986
• Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with Levodopa
  BMJ, 1971